About Pulmatrix (PULM)
Pulmatrix, Inc. is a clinical-stage biopharmaceutical company, which is focused on developing inhaled therapies to address serious pulmonary diseases and central nervous system (CNS) disorders using its patented inhaled small particles easily respira... Read more
- USD8.02
- USD8.14
- USD7.77
- USD10.40
- 22.00%
- 2M
- 16.49k
- 27.48k
- 32M
- 1.78
- 313.20%
Stock News
7 hours ago
United Natural Foods: Temporary Setback, Long-Term Opportunity
SeekingAlpha
9 hours ago
Why IONQ, RGTI and QBTS are Worth the Risk in Quantum Computing
Yahoo
10 hours ago
Arbe Robotics: I See The Vision, But Not The Business
SeekingAlpha
yesterday
'Functional freeze' could be the reason even successful people struggle to get out of bed some days: Here's what it means
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
